C4 Therapeutics
CCCC
CCCC
114 hedge funds and large institutions have $103M invested in C4 Therapeutics in 2025 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+1
Holders Change %
+0.88%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
27
Increased
39
Reduced
29
Closed
23
Calls
$127K
Puts
$4K
Net Calls
+$123K
Net Calls Change
-$1.8M
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$3.92M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.12M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1.04M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$780K |
| 5 |
SG Americas Securities
New York
|
+$680K |
